Non-cell autonomous or secretory tumor suppression.

Area of Science:

• Cancer Biology
• Molecular Oncology
• Cellular Signaling

Background:

• Malignancies often arise from loss-of-function mutations in tumor suppressor genes.
• Most tumor suppressors function within the cell where they are produced (cell-autonomous).
• A limited number of proteins exhibit non-cell autonomous tumor suppressor activity.

Purpose of the Study:

• To explore the expanding understanding of non-cell autonomous tumor suppressor functions.
• To highlight mechanisms by which tumor suppressors can impact neighboring cells.
• To discuss implications for developing novel cancer therapies.

Main Methods:

• Review of recent scientific literature on non-cell autonomous tumor suppressor mechanisms.
• Analysis of examples including secreted frizzled-related proteins (SFRPs), SPARC-related proteins, p53, and phosphatase and tensin homolog (PTEN).
• Discussion of intracellular and extracellular secretion pathways for tumor suppressor action.

Main Results:

• Non-cell autonomous tumor suppression can occur via secreted factors conditioning an anti-tumor microenvironment (e.g., p53).
• Tumor suppressors can be secreted and taken up by other cells, retaining activity (e.g., PTEN).
• Both conventional and unconventional secretion pathways contribute to non-cell autonomous PTEN function.

Conclusions:

• The concept of non-cell autonomous tumor suppression is broader than previously appreciated.
• Understanding these mechanisms offers new therapeutic avenues for recalcitrant tumors.
• Targeting extracellular tumor suppressor activity could overcome resistance in cancer treatment.